NCT00208351

Brief Summary

The purpose of this study is to compare the performance of 4 designs of the DePuy Ultima LX hip stem in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be randomly allocated to one of the 4 designs of the DePuy Ultima LX hip stem and will be evaluated at regular intervals following hip surgery using patient, clinical and x-ray assessments.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
164

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started May 1997

Longer than P75 for phase_3

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 1997

Completed
7.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2004

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

September 13, 2005

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 21, 2005

Completed
9.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2015

Completed
Last Updated

May 11, 2016

Status Verified

March 1, 2016

Enrollment Period

7.5 years

First QC Date

September 13, 2005

Last Update Submit

May 9, 2016

Conditions

Keywords

HipCemented

Outcome Measures

Primary Outcomes (1)

  • Stem movement measured radiographically at 2 years

    Stem movement was measured radiographically by comparing baseline stem position with the stem position 2 years after surgery. If migration was observed to be 5 or more mm, it was considered clinically significant migration.

    2yrs post-surgery

Secondary Outcomes (1)

  • Comparisons of Visual Analog Pain (VAS), 36-Item Short Form Health Survey (SF-36), Satisfaction, Limb Length and stem movement measured radiographically at 5 years.

    5yrs post-surgery

Study Arms (4)

1) Ultima LX Collared Stem - Non-Polished/Blasted Finished

ACTIVE COMPARATOR

A collared non-polished blasted finished cementless femoral component for use in total hip replacement.

Device: Ultima LX Collared Stem - Non-Polished/Blasted Finished

2) Ultima LX Collared Stem - Polished Finished

ACTIVE COMPARATOR

A collared polished finished cementless femoral component for use in total hip replacement.

Device: Ultima LX Collared Stem - Polished Finished

3) Ultima LX Collarless Stem - Non-Polished/Blasted Finished

ACTIVE COMPARATOR

A collarless non-polished/blasted finished cementless femoral component for use in total hip replacement.

Device: Ultima LX Collarless Stem - Non-Polished/Blasted Finished

4) Ultima LX Collarless Stem - Polished Finished

ACTIVE COMPARATOR

A collarless polished finished cementless femoral component for use in total hip replacement.

Device: Ultima LX Collarless Stem - Polished finished

Interventions

A collared non-polished/blasted finished cementless femoral component for use in total hip replacement.

1) Ultima LX Collared Stem - Non-Polished/Blasted Finished

A collared polished finished cementless femoral component for use in total hip replacement.

2) Ultima LX Collared Stem - Polished Finished

A collarless non-polished/blasted finished cementless femoral component for use in total hip replacement.

3) Ultima LX Collarless Stem - Non-Polished/Blasted Finished

A collarless polished finished cementless femoral component for use in total hip replacement.

4) Ultima LX Collarless Stem - Polished Finished

Eligibility Criteria

Age60 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Current indications for primary total hip arthroplasty utilising a cemented femoral component. These include pain, deformity and loss of function which are not responsive to medical treatment

You may not qualify if:

  • i) Revision Total Hip Arthroplasty ii) Rheumatoid arthritis iii) Age greater than 80 years at time of surgery iv) Age less than 60 years at time of surgery v) Previous hip joint sepsis vi) Obesity vii) Patient likely to remain housebound once rehabilitation is complete

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Epsom General Hospital

Surrey, KT18 7EG, United Kingdom

Location

Related Publications (1)

  • Hutt J, Hazlerigg A, Aneel A, Epie G, Dabis H, Twyman R, Cobb A. The effect of a collar and surface finish on cemented femoral stems: a prospective randomised trial of four stem designs. Int Orthop. 2014 Jun;38(6):1131-7. doi: 10.1007/s00264-013-2256-z. Epub 2014 Jan 29.

MeSH Terms

Conditions

OsteoarthritisCollagen DiseasesOsteonecrosisHip Dislocation, CongenitalSlipped Capital Femoral Epiphyses

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesBone DiseasesNecrosisPathologic ProcessesPathological Conditions, Signs and SymptomsDevelopmental Dysplasia of the HipMusculoskeletal AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesOsteochondrodysplasiasBone Diseases, DevelopmentalEpiphyses, Slipped

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 13, 2005

First Posted

September 21, 2005

Study Start

May 1, 1997

Primary Completion

November 1, 2004

Study Completion

March 1, 2015

Last Updated

May 11, 2016

Record last verified: 2016-03

Locations